Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mitral Regurgitation III: Medical Management

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

Mitral Valve Prolapse II: Assessment and Management

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

Endocarditis III: Medical Management

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...

Mitral Regurgitation I: Introduction

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Left atrial appendage exclusion during open cardiac surgery in patients without atrial fibrillation reduces 4-year ischemic stroke and mortality.

JTCVS structural and endovascular·2026

Same author

Long-term durability of bioprosthetic aortic valve replacement in young patients with bicuspid aortic stenosis.

JTCVS structural and endovascular·2026

Same author

Left and Right Heart Remodelling at 1 Year After Transcatheter Versus Surgical Aortic Valve Replacement: A Speckle-Tracking Echocardiography Study.

Interdisciplinary cardiovascular and thoracic surgery·2026

Same author

Postoperative 4-chamber cardiac function and outcomes following biatrial or left atrial Maze procedure for concomitant atrial fibrillation.

JTCVS open·2026

Same author

Artificial Intelligence Identification of Heart Failure With Preserved Ejection Fraction Substrate in Cardiac Surgery Patients.

Annals of thoracic surgery short reports·2026

Same author

Do Outcomes After Cardiac Surgery Differ by Preoperative Status and Socioeconomic Deprivation?

Annals of thoracic surgery short reports·2026

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Evolving indications for tricuspid valve surgery.

Patrick M McCarthy¹, Virna L Sales

¹Division of Cardiac Surgery, Feinberg School of Medicine, Northwestern University, 201 East Huron Street, Suite 11-140, Chicago, IL, 60611-2908, USA, pmccart@nmh.org.

Current Treatment Options in Cardiovascular Medicine

|November 11, 2010

Summary

This summary is machine-generated.

Guidelines for tricuspid valve (TV) surgery remain unclear, especially for less severe regurgitation (TR) or when not combined with mitral valve surgery. Recent publications offer improved guidance for TV repair and replacement decisions.

More Related Videos

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

Related Experiment Videos

Last Updated: Jun 6, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

Area of Science:

Cardiology
Cardiac Surgery
Clinical Guidelines

Background:

The tricuspid valve (TV) receives less attention than the mitral valve (MV), leading to ambiguity in surgical timing for tricuspid regurgitation (TR).
Existing guidelines present areas of agreement, disagreement, and silence regarding TV surgery indications.

Purpose of the Study:

To review current guidelines (ACC/AHA, ESC) for tricuspid valve surgery.
To clarify decision-making for tricuspid regurgitation (TR) management, particularly in the context of mitral valve surgery and other clinical scenarios.
To synthesize recent evidence on tricuspid valve repair and replacement outcomes.

Main Methods:

Comparative analysis of American College of Cardiology/American Heart Association and European Society of Cardiology guidelines.
Review of recent scientific literature on tricuspid valve surgery outcomes.
Expert opinion synthesis from Northwestern University regarding guideline interpretation and application.

Main Results:

Guidelines show concordance for severe TR during MV surgery.
Discordance exists for less severe TR with recurrence risk factors (e.g., pulmonary hypertension, atrial fibrillation).
Guidelines are silent on TR in patients undergoing non-MV operations, and primary TR surgery indications require further clarification.

Conclusions:

Current guidelines offer partial clarity on tricuspid valve surgery timing, especially in complex cases.
Emerging data on TV repair and replacement are crucial for refining surgical decision-making.
Further research and guideline refinement are needed for optimal management of tricuspid regurgitation.